RheumNow Live 2025

Advanced Rheumatology, Autoimmune Disease & Clinical Immunology Update

The RheumNow Live 2025 course delivers a comprehensive clinical update on the latest developments in rheumatology, autoimmune diseases, and clinical immunology. Featuring internationally recognized experts, this program focuses on practical strategies for integrating emerging therapies, advanced imaging techniques, and evolving treatment guidelines into everyday rheumatology practice.

The course provides extensive coverage of rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, systemic lupus erythematosus (SLE), vasculitis, and other immune-mediated inflammatory diseases. Particular emphasis is placed on the rapidly expanding role of biologic therapies, JAK inhibitors, TYK2 inhibitors, precision medicine, and personalized treatment approaches.

Designed to address both common and complex clinical scenarios, RheumNow Live 2025 equips clinicians with evidence-based tools to optimize patient outcomes while navigating safety concerns, multimorbidity, treatment sequencing, and long-term disease management.

Product Details

• Course Date: 2025
• Format: 37 Videos
• Size: 22.78 GB
• Access: On-Demand
• Provider: RheumNow

Program Overview

Rheumatology continues to evolve rapidly with the introduction of novel biologics, targeted synthetic DMARDs, advanced imaging technologies, and updated treatment paradigms. Clinicians must balance disease control, safety considerations, patient preferences, and comorbidities while implementing increasingly sophisticated therapeutic strategies.

RheumNow Live 2025 provides practical, evidence-based education covering:

• Rheumatoid Arthritis (RA)
• Psoriatic Arthritis (PsA)
• Axial Spondyloarthritis (axSpA)
• Ankylosing Spondylitis
• Systemic Lupus Erythematosus (SLE)
• Vasculitis
• Osteoarthritis
• Autoimmune Disease Management
• Clinical Immunology
• Biologic Therapies
• JAK Inhibitors
• TYK2 Inhibitors
• Advanced Imaging
• Precision Medicine
• Multimorbidity Management

The program emphasizes clinical decision-making, real-world patient care, and practical implementation of emerging therapies.

Learning Objectives

Upon completion of this activity, participants will be able to:

• Evaluate the efficacy and safety of biologic therapies, JAK inhibitors, and TYK2 inhibitors across rheumatic diseases.
• Apply updated treatment guidelines for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, lupus, and vasculitis.
• Utilize advanced imaging techniques for diagnosis, monitoring, and disease assessment.
• Develop individualized treatment strategies based on disease activity, comorbidities, and patient-specific factors.
• Manage complex autoimmune conditions while minimizing treatment-related risks.
• Integrate emerging evidence into routine rheumatology practice.

Rheumatoid Arthritis Updates

A major component of the conference focuses on contemporary rheumatoid arthritis management.

Topics include:

• Early rheumatoid arthritis
• Treat-to-target strategies
• Disease activity monitoring
• Remission optimization
• Biologic sequencing
• JAK inhibitor utilization
• Elderly RA patients
• Multimorbidity considerations
• Difficult-to-treat rheumatoid arthritis
• Long-term safety monitoring

Faculty discuss practical approaches for achieving sustained disease control while minimizing adverse events.

Psoriatic Arthritis & Psoriasis

Dedicated sessions explore the evolving relationship between psoriasis and psoriatic arthritis.

Topics include:

• Early identification of PsA
• Prevention strategies
• Biologic selection
• Skin-joint disease integration
• Enthesitis management
• Dactylitis treatment
• Axial involvement
• Comparative biologic studies
• Long-term outcomes

Participants learn how aggressive psoriasis management may reduce progression to psoriatic arthritis.

Spondyloarthritis & Axial Disease

The course provides extensive updates on spondyloarthritis diagnosis and treatment.

Topics include:

• Axial spondyloarthritis
• Ankylosing spondylitis
• Non-radiographic axial SpA
• MRI interpretation
• Disease progression monitoring
• Biologic therapy optimization
• Extra-articular manifestations
• Treatment sequencing

Experts review current imaging recommendations and evolving therapeutic options.

Systemic Lupus Erythematosus (SLE)

Sessions on lupus focus on advances in disease monitoring and treatment.

Topics include:

• Updated SLE treatment guidelines
• Steroid minimization strategies
• Interferon-targeted therapies
• Biologic therapies in lupus
• Lupus nephritis
• Disease activity assessment
• Precision medicine approaches
• Long-term management

Faculty discuss how newer therapies are changing outcomes for patients with lupus.

Vasculitis Management

The program reviews modern approaches to diagnosing and treating vasculitic diseases.

Topics include:

• Large-vessel vasculitis
• Small-vessel vasculitis
• ANCA-associated vasculitis
• Giant cell arteritis
• Imaging strategies
• Glucocorticoid-sparing approaches
• Biologic therapies
• Monitoring disease activity

Participants gain practical tools for managing these complex inflammatory disorders.

JAK Inhibitors & TYK2 Inhibitors

A key focus of RheumNow Live 2025 is the expanding role of targeted therapies.

Topics include:

• JAK inhibitor efficacy
• Safety considerations
• Cardiovascular risk assessment
• Infection monitoring
• TYK2 inhibitor development
• Comparative effectiveness studies
• Patient selection strategies
• Treatment sequencing

Faculty discuss how targeted therapies fit into modern rheumatology treatment algorithms.

Advanced Imaging in Rheumatology

Imaging continues to play a critical role in rheumatic disease diagnosis and monitoring.

Topics include:

• MRI in spondyloarthritis
• Musculoskeletal ultrasound
• Imaging biomarkers
• Vasculitis imaging
• Structural progression assessment
• Early disease detection
• Monitoring therapeutic response

Participants learn how imaging improves diagnostic accuracy and treatment planning.

Precision Medicine & Personalized Care

The conference highlights individualized approaches to autoimmune disease management.

Topics include:

• Biomarker-guided therapy
• Personalized treatment selection
• Risk stratification
• Disease phenotyping
• Therapeutic optimization
• Shared decision-making
• Long-term patient monitoring

Faculty explore how precision medicine is transforming rheumatology care.

Target Audience

This course is ideal for:

• Rheumatologists
• Clinical Immunologists
• Internal Medicine Physicians
• Autoimmune Disease Specialists
• Rheumatology Fellows
• Advanced Practice Providers
• Nurse Practitioners
• Physician Assistants
• Clinical Researchers
• Healthcare Professionals Involved in Rheumatic Disease Care

   Topics

1. Adjourn

2. Advances in Treatment of Spondyloarthritis

3. AI applied to Rheumatoid Arthritis Care Practically Not Perfect

4. BIMZELX bimekizumab-bkzx Expert Perspectives on a New Treatment for PsA nr-axSpA and AS by Dr Evan Siegel

5. Can Aggressive Treatment of Psoriasis Prevent PsA

6. Combination Biologic Therapies in PsA

7. Dermatomyositis Updates Insights and JAK-Is too

8. Head-to-head Studies in Psoriatic Disease What have we learned

9. Imaging Evaluation of Spondyloarthritis

10. Imaging in Vasculitis

11. Interferons Role in SLE

12. JAK Faculty Panel Discussion with QA

13. JAK Inhibitors – POD III

14. Key Considerations Managing Older Adults with RA

15. KEYNOTE LECTURE Reinventing Oneself in Medicine

16. Management of EGPA in 2025 and Beyond

17. Modern Treatment of PMR

18. Multimorbidity in RA What to Do and Who Should Do It

19. Optimizing Care for PMR Advances and Challenges in Diagnosis and Treatment by Adam Brown MD Rheumatologist at C…

20. POD 7 Spondyloarthritis

21. POD I – Rheumatoid Arthritis

22. POD V Vasculitis

23. Progress in Hidradenitis Supprativa

24. Psoriatic Arthritis – POD II

25. Psoriatic Faculty Panel Discussion with QA

26. Rheumatoid Faculty Panel Discussion with QA

27. Spondyloarthritis Faculty Panel Discussion with QA

28. STEP Environmental Rheumatology

29. STEP Flares of Rheumatoid Arthritis

30. STEP Morphea and Linear Scleroderma

31. STEP New Steroid Rules for Lupus

32. STEP Oral Surveillance 3 years later

33. STEP Performance Art and Medicine

34. TYK2 Inhibitors Where do they fit

35. Vasculitis Faculty Panel Discussion with QA

36. Welcome Introductions

37. When JAKs Go Generic